BioNexus Gene Lab
BGLC
#11183
Rank
โ‚ฌ2.18 M
Marketcap
0,75ย โ‚ฌ
Share price
-9.43%
Change (1 day)
-81.47%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2026 (TTM): -0,93ย โ‚ฌ

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -0,98ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,46ย โ‚ฌ a decrease over its 2024 EPS that were of -0,81ย โ‚ฌ.

EPS history for BioNexus Gene Lab from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,93ย โ‚ฌ-36.6%
2025-1,46ย โ‚ฌ79.15%
2024-0,81ย โ‚ฌ-45.96%
2023-1,51ย โ‚ฌ260.87%
2022-0,42ย โ‚ฌ-195.83%
20210,44ย โ‚ฌ-66.67%
20201,31ย โ‚ฌ-600.17%
2019-0,26ย โ‚ฌ-1031.69%
20180,02807ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 24.88%๐Ÿ‡บ๐Ÿ‡ธ USA